Okupe Oluyemi 4

What Happened Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), exercised 6,376 stock options at $5.01 per share (cost $31,944) and reported an open‑market sale of 18,197 shares at an average weighted price of $34.03 for proceeds of $619,217. The Form 4 also shows a derivative conversion/settlement of 6,376 shares reported as disposed at $0.

Key Details

• Transaction date: June 22, 2026; Form 4 filed June 23, 2026 (appears timely).
• Option exercise: 6,376 shares acquired at $5.01 per share — total cost $31,944.
• Open‑market sale: 18,197 shares sold; average weighted price $34.03; total proceeds $619,217. Reported sale price range: $33.65–$34.57 (per footnote).
• Derivative line: 6,376 shares reported as disposed at $0 (reported as a derivative/settlement).
• Plan note: Sales and option exercises were effected under a Rule 10b5‑1 trading plan adopted May 21, 2025 (footnote).
• Vesting note: Options vest 25% one year after a Jan 24, 2022 vesting commencement date, then monthly over 36 months (footnote).
• Shares owned after the transactions: not specified in the information provided in your summary.

Context

• The filing shows an option exercise paired with a separate open‑market sale; the derivative disposal at $0 may reflect conversion/settlement mechanics reported on the Form 4 but the filing does not detail whether the exercised shares were the ones sold (i.e., a cashless exercise).
• Sales executed under a pre‑arranged 10b5‑1 plan are generally routine and planned in advance; they are disclosures of insider activity, not direct evidence of the insider’s short‑term view.